Cleerly ISCHEMIA vs Stethee Pro 1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by M3DICINE

AI Verdict

Cleerly ISCHEMIA is an AI tool specializing in the non-invasive detection of coronary artery ischemia and plaque characterization through CCTA scan analysis. In contrast, Stethee Pro 1 is an AI-enabled wireless digital stethoscope system focused on real-time cardiac and respiratory vital sign analysis and sound amplification. While both contribute to cardiology diagnostics, they utilize distinct data sources and address different aspects of cardiovascular assessment.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if your primary need is a comprehensive, non-invasive assessment of coronary artery disease, leveraging CCTA scans to precisely determine vessel-level ischemia likelihood and characterize coronary plaque. This tool is ideal for detailed diagnostic workups requiring an in-depth understanding of coronary anatomy and functional significance for personalized treatment planning.

View Cleerly ISCHEMIA →

Choose Stethee Pro 1 if…

Choose Stethee Pro 1 if you require a portable, real-time solution for immediate cardiac and respiratory vital sign analysis and auscultation, especially in remote monitoring, telemedicine, or emergency settings. This AI-enabled digital stethoscope excels at quick, on-the-spot assessments, capturing and securely sharing high-quality physiological data to enhance physical examinations.

View Stethee Pro 1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA Stethee Pro 1
Pricing Unknown $499 usd
Deployment Web-based solution Cloud, Mobile
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Stethee Pro 1

Stethee Pro 1 (Tool B) offers a more immediate and mobile-friendly user experience with its physical device and dedicated mobile application, enabling real-time visualization and data capture at the point of care. Cleerly ISCHEMIA (Tool A), while providing comprehensive web-based reports, operates more within a post-scan analysis workflow.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA (Tool A) provides a deeper, non-invasive assessment of coronary artery disease, including vessel-level ischemia likelihood and detailed plaque characterization from CCTA scans, which can significantly influence treatment pathways and potentially reduce the need for invasive procedures. Stethee Pro 1 (Tool B) enhances a traditional diagnostic tool for real-time cardiac and respiratory vital sign analysis.

Pricing & Value

Stethee Pro 1

Stethee Pro 1 (Tool B) offers transparent pricing for its device and clearly states a subscription model for its advanced analytics portal, allowing potential users to understand the cost upfront. Cleerly ISCHEMIA (Tool A) provides opaque pricing, requiring direct contact and varying by provider, which makes it difficult to assess its value proposition without further inquiry.

Enterprise Readiness

Cleerly ISCHEMIA

Both tools are FDA-cleared and HIPAA compliant. Cleerly ISCHEMIA (Tool A) explicitly states the availability of a BAA and offers robust integration capabilities with existing radiology workflows via API and secure data transfer methods like VPN/virtual appliance, indicating a strong focus on enterprise-level deployment and data security.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA (Tool A) represents a significant innovation in cardiac imaging by leveraging AI to non-invasively derive complex physiological parameters like FFR and detailed plaque characteristics from CCTA scans, potentially transforming diagnostic pathways for coronary artery disease. While Stethee Pro 1 (Tool B) innovates on the traditional stethoscope, its core function remains auscultation, albeit enhanced with AI and connectivity.

Support & Docs

Stethee Pro 1

Stethee Pro 1 (Tool B) provides extensive user-facing documentation, including a detailed 'Getting Started' guide and a mobile app tutorial and user manual, readily available online. While Cleerly (Tool A) offers resources for providers regarding billing and integration, its publicly visible user-specific support and documentation appear less comprehensive for direct product usage.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA Stethee Pro 1
Core Function/Modality AI tool analyzing CCTA scans for coronary artery ischemia likelihood. AI-enabled wireless digital stethoscope system for cardiac and respiratory vital sign analysis.
Primary Specialties Cardiology, Radiology Cardiology, Emergency Medicine, Pulmonology
Key AI-enabled Analysis Non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood, coronary plaque characterization, stenosis severity assessment. Real-time cardiac and respiratory vital sign analysis, measures systole, diastole, heart cycle durations, respiration rate, real-time visualization of heart and lung sounds.
Data Transfer/Sharing Capabilities Data transfer via Cleerly Proxy (VPN or virtual appliance), integration with PowerScribe via API. Secure data capture, analysis, recording, playback, and sharing capabilities via mobile app and HIPAA compliant Central Web Portal.

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Stethee Pro 1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. Stethee Pro 1 is an FDA-cleared, AI-enabled wireless digital stethoscope system that provides real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing for enhanced diagnostics and telemedicine.
Cleerly ISCHEMIA analyzes data sets from coronary computed tomography angiography (CCTA) scans. Stethee Pro 1 captures cardiac and respiratory vital signs and sounds using its AI-enabled wireless digital stethoscope system.
Cleerly ISCHEMIA provides vessel-level ischemia likelihood determination, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization (volume, type, location), and stenosis severity assessment, along with 3D digital models of coronary arteries and comprehensive interactive web-based reports. Stethee Pro 1 measures systole, diastole, heart cycle durations, and respiration rate, offering sophisticated sound amplification (up to 96x), five proprietary digital filters, and real-time visualization of heart (PCG, AIDA Cycle, AIDA Energy) and lung sounds (spectrogram). It also includes automatic geo-location and environmental data tagging such as humidity, temperature, pollen count, and pollution.
Cleerly ISCHEMIA is designed for Cardiology and Radiology specialties. Stethee Pro 1 supports Cardiology, Emergency Medicine, and Pulmonology.
Yes, both Cleerly ISCHEMIA and Stethee Pro 1 are FDA-cleared and HIPAA compliant. Cleerly ISCHEMIA explicitly states it has a Business Associate Agreement (BAA), while Stethee Pro 1 indicates it is likely to have one given its HIPAA compliance and handling of protected health information.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.